UK Biobank observational study links wrist-measured nighttime light above 3 lux to left ventricular wall thickening and reduced cardiac strain on MRI
Observational wrist-sensor and MRI data show nighttime light above 3 lux correlates with adverse cardiac remodeling, extending prior epidemiological links between light pollution and CVD. Residual confounding and lack of repeated imaging limit causal inference. Randomized light-reduction trials are required to test reversibility and clinical endpoints.
Researchers measured ambient light continuously via wrist actigraphy then obtained standardized cardiac MRI metrics including wall thickness, chamber volumes, and global longitudinal strain. Participants above the 3-lux threshold showed concentric remodeling of the left ventricle, reduced right-ventricular ejection fraction, and left-atrial enlargement compared with those below 1 lux; no absolute incidence rates or hazard ratios were reported. The design cannot separate light exposure from correlated behaviors such as shift work, screen use, or socioeconomic status, leaving residual confounding possible. The findings align with prior Münzel-led reviews in European Heart Journal 2023 that documented higher CVD hospitalization rates in brightly lit urban zones and with a 2022 JAMA Cardiology analysis linking self-reported bedroom light to incident heart failure. Together they suggest a dose-dependent pathway from circadian disruption to myocardial fibrosis, yet the current study supplies the first direct imaging evidence of structural change. Next steps require longitudinal cohorts with repeated MRI and randomized interventions that reduce bedroom light below 1 lux while tracking strain trajectories over five years. Public-health modeling should quantify how many incident heart-failure cases might be averted by municipal lighting ordinances. Clinicians may begin documenting sleep-environment light levels in heart-failure intake, but policy recommendations await trials that isolate light from co-exposures.
European Society of Cardiology: within 48 months at least one randomized bedroom-light intervention trial will report change in global longitudinal strain as a powered secondary endpoint
Sources (3)
- [1]Primary Source(https://doi.org/10.1093/eurheartj/ehag563)
- [2]Supporting Source(https://doi.org/10.1093/eurheartj/ehad095)
- [3]Supporting Source(https://doi.org/10.1016/j.jacc.2022.08.754)